Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2009)10.1056/nejmoa0905561Source: DataRank Database

Dabigatran versus Warfarin in Patients with Atrial Fibrillation is a research paper published in New England Journal of Medicine (2009). On theSindex it has a DataRank of 1.4. It has been cited 11,147 times.

N/A

1.4DataRank · unranked

Scored on demand from live citation data

Open Access11,147 citations

Free full text

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 349.46)OA: bronzeTopics (57)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.4

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (25)

Michael D. Ezekowitz ORCID,Salim Yusuf ORCID,John Eikelboom,Jonas Oldgren ORCID,Amit Parekh ORCID

Live enrichment

PubMed:19717844 OpenAlex:https://openalex.org/W2136489990

FWCI

349.46

Citation Percentile

1.0%

Citation Trend

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: other-oa

journalhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561?articleTools=true

publisherhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561?articleTools=true

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561

journalhttps://doi.org/10.1056/nejmoa0905561

repositoryhttps://pubmed.ncbi.nlm.nih.gov/19717844

Fields of Study

Atrial Fibrillation Management and OutcomesIntracerebral and Subarachnoid Hemorrhage ResearchVenous Thromboembolism Diagnosis and ManagementAgedAnticoagulantsAtrial FibrillationBenzimidazolesChi-Square DistributionDabigatranDouble-Blind MethodDyspepsiaEmbolismFemaleFollow-Up StudiesHemorrhageHumansLiverMaleMiddle AgedMyocardial InfarctionProdrugsProportional Hazards ModelsPyridinesStrokeWarfarin

MeSH Terms

DabigatranAgedAnticoagulantsAtrial FibrillationBenzimidazolesDouble-Blind MethodDyspepsiaEmbolismFemaleFollow-Up StudiesHemorrhageHumansLiverMaleMiddle AgedMyocardial InfarctionProdrugsPyridinesWarfarinChi-Square DistributionProportional Hazards ModelsStroke

Keywords

DabigatranMedicineWarfarinAtrial fibrillationStroke (engine)Confidence intervalAnesthesiaInternal medicineRelative riskDirect thrombin inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation – a qualitative study

10.6084/m9.figshare.13291039.v1figshare

Additional file 1 of Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation – a qualitative study

10.6084/m9.figshare.13291039figshare

Additional file 1 of Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial

10.6084/m9.figshare.13487341.v1figshare

Additional file 1 of Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial

10.6084/m9.figshare.13487341figshare

Additional file 1 of Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis

10.6084/m9.figshare.13671102.v1figshare

Additional file 1 of Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis

10.6084/m9.figshare.13671102figshare

Additional file 1 of Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

10.6084/m9.figshare.14677006.v1figshare

10.6084/m9.figshare.14677006figshare

Additional file 1 of Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences

10.6084/m9.figshare.15153829.v1figshare

10.6084/m9.figshare.15153829figshare

Additional file 1 of Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

10.6084/m9.figshare.16570909.v1figshare

Additional file 1 of Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

10.6084/m9.figshare.16570909figshare

Additional file 1 of Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

10.6084/m9.figshare.16703224.v1figshare

Additional file 1 of Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

10.6084/m9.figshare.16703224figshare

Additional file 1 of Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends

10.6084/m9.figshare.16807549.v1figshare

Additional file 1 of Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends

10.6084/m9.figshare.16807549figshare

Additional file 1 of Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study

10.6084/m9.figshare.16829368.v1figshare

Additional file 1 of Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study

10.6084/m9.figshare.16829368figshare

Additional file 1 of How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia

10.6084/m9.figshare.16969078.v1figshare

Additional file 1 of How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia

10.6084/m9.figshare.16969078figshare